Neuronetics (STIM)
(Delayed Data from NSDQ)
$1.46 USD
+0.13 (9.77%)
Updated Dec 24, 2024 01:00 PM ET
After-Market: $1.43 -0.03 (-2.05%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Neuronetics (STIM) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $2.67 | $3.00 | $2.00 | 82.88% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Neuronetics comes to $2.67. The forecasts range from a low of $2.00 to a high of $3.00. The average price target represents an increase of 82.88% from the last closing price of $1.46.
Analyst Price Targets (3 )
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
Neuronetics currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, three are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 11/12/2024 | William Blair | Margaret K Andrew | Hold | Hold |
| 8/14/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
| 8/13/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.50 |
| ABR (Last week) | 1.50 |
| # of Recs in ABR | 4 |
| Average Target Price | $2.67 |
| LT Growth Rate | NA |
| Industry | Medical - Instruments |
| Industry Rank by ABR | 49 of 251 |
| Current Quarter EPS Est: | -0.26 |
STIM FAQs
Neuronetics, Inc. (STIM) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Neuronetics, Inc. (STIM) is $2.67. The current on short-term price targets is based on 2 reports.
The forecasts for Neuronetics, Inc. (STIM) range from a low of $2 to a high of $3. The average price target represents a increase of $82.88 from the last closing price of $1.46.
The current UPSIDE for Neuronetics, Inc. (STIM) is 82.88%
Based on short-term price targets offered by three analysts, the average price target for Neuronetics comes to $2.67. The forecasts range from a low of $2.00 to a high of $3.00. The average price target represents an increase of 82.88% from the last closing price of $1.46.